Targeting Energy Metabolism in Cancer Treatment

Area of Science:

• Biochemistry
• Oncology
• Metabolic pathways

Background:

• Cancer is a leading cause of death globally, with treatment resistance a significant challenge.
• Molecular and biochemical advancements have illuminated cancer cell-specific metabolic alterations.
• Key metabolic pathways like glycolysis, Krebs cycle, and pentose phosphate pathway are altered in cancer.

Purpose of the Study:

• To review current knowledge on enzymes in key metabolic pathways in cancer cells.
• To explore targeted therapies based on metabolic differences between cancer and normal cells.
• To highlight the metabolic phenotype differences between cancer and normal cells.

Main Methods:

• Literature review of metabolic pathways in cancer.
• Analysis of enzymes involved in glycolysis, Krebs cycle, and pentose phosphate pathway.
• Comparison of metabolic phenotypes of cancer versus normal cells.

Main Results:

• Cancer cells exhibit increased aerobic glycolysis and dependence on glutamine and fatty acid metabolism.
• Specific enzymes in glycolysis, Krebs cycle, and pentose phosphate pathway are potential therapeutic targets.
• Metabolic phenotype differences provide a basis for targeted anti-cancer strategies.

Conclusions:

• Targeting cancer cell metabolism offers a promising avenue for novel therapeutic strategies.
• Further research into cancer metabolism is essential for developing more effective and less toxic treatments.
• Understanding metabolic reprogramming is key to overcoming therapeutic resistance in neoplastic diseases.